Related references
Note: Only part of the references are listed.Hypersensitive IFN Responses in Lupus Keratinocytes Reveal Key Mechanistic Determinants in Cutaneous Lupus
Lam C. Tsoi et al.
JOURNAL OF IMMUNOLOGY (2019)
SOX2 Epidermal Overexpression Promotes Cutaneous Wound Healing via Activation of EGFR/MEK/ERK Signaling Mediated by EGFR Ligands
Akihiko Uchiyama et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2019)
Shared and Distinct Functions of Type I and Type III Interferons
Helen M. Lazear et al.
IMMUNITY (2019)
Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways
Evan Der et al.
NATURE IMMUNOLOGY (2019)
Comprehensive Integration of Single-Cell Data
Tim Stuart et al.
CELL (2019)
Interferon-λ modulates dendritic cells to facilitate T cell immunity during infection with influenza A virus
Emily A. Hemann et al.
NATURE IMMUNOLOGY (2019)
Differential Activation of the Transcription Factor IRF1 Underlies the Distinct Immune Responses Elicited by Type I and Type III Interferons
Adriana Forero et al.
IMMUNITY (2019)
Reference-based analysis of lung single-cell sequencing reveals a transitional profibrotic macrophage
Dvir Aran et al.
NATURE IMMUNOLOGY (2019)
Interferon-λ orchestrates innate and adaptive mucosal immune responses
Liang Ye et al.
NATURE REVIEWS IMMUNOLOGY (2019)
Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial
Daniel J. Wallace et al.
LANCET (2018)
Up-Regulation of TLR7-Mediated IFN-α Production by Plasmacytoid Dendritic Cells in Patients With Systemic Lupus Erythematosus
Kei Sakata et al.
FRONTIERS IN IMMUNOLOGY (2018)
Interferon-λ3/4 genetic variants and interferon-λ3 serum levels are biomarkers of lupus nephritis and disease activity in Taiwanese
Ji-Yih Chen et al.
ARTHRITIS RESEARCH & THERAPY (2018)
TLR7 escapes X chromosome inactivation in immune cells
Melanie Souyris et al.
SCIENCE IMMUNOLOGY (2018)
Peptidylarginine deiminases 2 and 4 modulate innate and adaptive immune responses in TLR-7 dependent lupus
Yudong Liu et al.
JCI INSIGHT (2018)
Tofacitinib Ameliorates Murine Lupus and Its Associated Vascular Dysfunction
Yasuko Furumoto et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Contribution of type III interferons to antiviral immunity: location, location, location
Sergei V. Kotenko et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation
Akrivi Chrysanthopoulou et al.
JOURNAL OF PATHOLOGY (2017)
Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus
Richard Furie et al.
ARTHRITIS & RHEUMATOLOGY (2017)
Interferon (IFN)-λ Takes the Helm: Immunomodulatory Roles of Type III IFNs
Ivan Zanoni et al.
FRONTIERS IN IMMUNOLOGY (2017)
IFN-λ suppresses intestinal inflammation by non-translational regulation of neutrophil function
Achille Broggi et al.
NATURE IMMUNOLOGY (2017)
Type III interferon is a critical regulator of innate antifungal immunity
Vanessa Espinosa et al.
SCIENCE IMMUNOLOGY (2017)
An update on lupus animal models
Wei Li et al.
CURRENT OPINION IN RHEUMATOLOGY (2017)
A Phase II study of the efficacy and safety of rontalizumab (rhuMAb interferon-alpha) in patients with systemic lupus erythematosus (ROSE)
Kenneth C. Kalunian et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Sifalimumab, an anti-interferon-α monoclonal antibody, in moderate to severe systemic lupus erythematosus: a randomised, double-blind, placebo-controlled study
Munther Khamashta et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
Immune Cell Profiling of IFN- Response Shows pDCs Express Highest Level of IFN-R1 and Are Directly Responsive via the JAK-STAT Pathway
Aoife Kelly et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2016)
Distinct Roles of Type I and Type III Interferons in Intestinal Immunity to Homologous and Heterologous Rotavirus Infections
Jian-Da Lin et al.
PLOS PATHOGENS (2016)
Interferon (IFN)-lambda is a potential mediator in lupus nephritis
Agneta Zickert et al.
LUPUS SCIENCE & MEDICINE (2016)
Interferon-λ: Immune Functions at Barrier Surfaces and Beyond
Helen M. Lazear et al.
IMMUNITY (2015)
IFN-λ resolves inflammation via suppression of neutrophil infiltration and IL-1β production
Katrina Blazek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2015)
IFN-λ is able to augment TLR-mediated activation and subsequent function of primary human B cells
Rik A. de Groen et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2015)
Predominant role of plasmacytoid dendritic cells in stimulating systemic autoimmunity
Xinfang Huang et al.
FRONTIERS IN IMMUNOLOGY (2015)
Limited effectiveness for the therapeutic blockade of interferon α in systemic lupus erythematosus: a possible role for type III interferons Type III interferons in lupus
Luis M. Amezcua-Guerra et al.
RHEUMATOLOGY (2015)
Type I Interferon in the Pathogenesis of Lupus
Mary K. Crow
JOURNAL OF IMMUNOLOGY (2014)
Epicutaneous Application of Toll-like Receptor 7 Agonists Leads to Systemic Autoimmunity in Wild-Type Mice
Maki Yokogawa et al.
ARTHRITIS & RHEUMATOLOGY (2014)
Sifalimumab, a Human AntiInterferon- Monoclonal Antibody, in Systemic Lupus Erythematosus: A Phase I Randomized, Controlled, Dose-Escalation Study
Michelle Petri et al.
ARTHRITIS AND RHEUMATISM (2013)
Type I Interferons Modulate Vascular Function, Repair, Thrombosis, and Plaque Progression in Murine Models of Lupus and Atherosclerosis
Seth G. Thacker et al.
ARTHRITIS AND RHEUMATISM (2012)
Profiling the expression of interleukin (IL)-28 and IL-28 receptor α in systemic lupus erythematosus patients
Shih-Chang Lin et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2012)
Evidence for a Pathophysiological Role of Keratinocyte-Derived Type III Interferon (IFN lambda) in Cutaneous Lupus Erythematosus
Sabine Zahn et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
MECHANISMS OF DISEASE Systemic Lupus Erythematosus
George C. Tsokos
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Interferon-lambda1 induces peripheral blood mononuclear cell-derived chemokines secretion in patients with systemic lupus erythematosus: its correlation with disease activity
Qian Wu et al.
ARTHRITIS RESEARCH & THERAPY (2011)
Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus
Nan Shen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
CXCR3+CD4+T Cells Are Enriched in Inflamed Kidneys and Urine and Provide a New Biomarker for Acute Nephritis Flares in Systemic Lupus Erythematosus Patients
P. Enghard et al.
ARTHRITIS AND RHEUMATISM (2009)
Despite IFN-lambda receptor expression, blood immune cells, but not keratinocytes or melanocytes, have an impaired response to type III interferons: implications for therapeutic applications of these cytokines
K. Witte et al.
GENES AND IMMUNITY (2009)
CXCR3 Mediates Renal Th1 and Th17 Immune Response in Murine Lupus Nephritis
Oliver M. Steinmetz et al.
JOURNAL OF IMMUNOLOGY (2009)
TLR7-dependent and FcγR-independent production of type I interferon in experimental mouse lupus
Pui Y. Lee et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice
Ulrike Lichti et al.
NATURE PROTOCOLS (2008)
IFN-lambda (IFN-λ) is expressed in a tissue-dependent fashion and primarily acts on epithelial cells in vivo
Caroline Sommereyns et al.
PLOS PATHOGENS (2008)
Type III interferon (IFN) induces a type IIFN-like response in a restricted subset of cells through signaling pathways involving both the Jak-STAT pathway and the mtogen-activated protein kinases
Zhangle Zhou et al.
JOURNAL OF VIROLOGY (2007)
Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9
Maria C. Lebre et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2007)
A Tlr7 translocation accelerates systemic autoimmunity in murine lupus
Srividya Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Lambda interferon (IFN-λ), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo
N Ank et al.
JOURNAL OF VIROLOGY (2006)
Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus
J Wenzel et al.
JOURNAL OF PATHOLOGY (2005)
Interferon and granulopoiesis signatures in systemic lupus erythematosus blood
L Bennett et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
IL-28, IL-29 and their class II cytokine receptor IL-28R
P Sheppard et al.
NATURE IMMUNOLOGY (2003)
IFN-lambda s mediate antiviral protection through a distinct class II cytokine receptor complex
SV Kotenko et al.
NATURE IMMUNOLOGY (2003)
Share Paper
